Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results

Last Modified: 11/19/2007


1.		Phase II Chemotherapy with HMBA in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemias

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				JHOC-87051401 NCI-T87-0130C, T87-0130

Last Modified: 12/1/1988


2.		Phase II Chemotherapy with HMBA in Patients with Malignant Melanoma (Summary Last Modified 12/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18				NCI				MSKCC-8774 NCI-T87-0079C, T87-0079

Last Modified: 8/1/1990


3.		Phase II Chemotherapy with Hexamethylene Bisacetamide in Patients with Myelodysplastic Syndromes and AML

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 18				NCI				MSKCC-87117A DFCI-86133, NCI-T87-0092C, T87-0092

Last Modified: 8/1/1988


4.		Phase II Chemotherapy with HMBA in Patients with Oral Leukoplakia (Summary Last Modified 08/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Completed				18 and over				NCI				UMCC-8729 NCI-T88-0011C, T88-0011

Last Modified: 3/1/1991


5.		Phase II Chemotherapy with Hexamethylene Bisacetamide in Patients with Stage III/IV non-Small Cell Lung Cancer (Summary Last Modified 03/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-88129 NCI-T88-0233C, T88-0233

Last Modified: 11/1/1991


6.		Phase II Trial of HMBA with Albuterol/Theophylline in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 11/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-90174A3 NCI-T90-0240D, T90-0240


7.		Phase I Study of Hexamethylene Bisacetamide in Patients with Advanced Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				20 to 75				NCI				JHOC-8434 NCI-T84-0447W, T84-0447


8.		Phase I Evaluation of Hexamethylene Bisacetamide in Patients with Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				no age specified				NCI				UMCC-8423 NCI-T84-0443W, T84-0443

Last Modified: 10/1/1990


9.		Phase I Evaluation of Hexamethylene Bisacetamide in Patients with Advanced Solid Tumors (Summary Last Modified 10/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				over 18				NCI				MSKCC-8587 NCI-T85-0222W, T85-0222

Last Modified: 9/1/1988


10.		Phase I Chemotherapy with Continuous Infusion Hexamethylene Bisacetamide in Patients with Solid Tumors (Summary Last Modified 09/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				UMCC-8533 NCI-T86-0006W, T86-0006

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute